Treatment of Pediatric Acute Lymphoblastic Leukemia in India as per modified BFM 95 protocol with Minimal Residual Disease monitoring

Treatment of Pediatric Acute Lymphoblastic Leukemia in India as per modified BFM 95 protocol with Minimal Residual Disease monitoring

Background: Survival outcomes of Pediatric Acute Lymphoblastic Leukemia (ALL) in the developing world have lagged. Here we report improved outcomes of pediatric ALL from India.Methods: We analyzed outcomes of children with ALL treated at our center between 2016 and 2021. They were treated as per the...

Full description

Bibliographic Details
Main Authors: Dhwanee Thakkar, K. Upasana, D. S. Udayakumar, Neha Rastogi, Ritu Chadha, Sunisha Arora, Bhawna Jha, Anjali Yadav, Shalini Goel, Renu Saxena, Satya Prakash Yadav
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Hematology
Subjects:
Acute Lymphoblastic Leukemia
BFM 95 protocol
Minimal Residual Disease
India
outcomes
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2439733

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2024.2439733

Similar Items